Spiegelman BM and Flier JS: Obesity and the regulation of energy balance. Cell. 104:531–543. 2001.PubMed/NCBI View Article : Google Scholar

Haslam DW and James WP: Obesity. Lancet. 366:1197–1209. 2005.PubMed/NCBI View Article : Google Scholar

Executive summary of the clinical guidelines on the identification evaluation and treatment of overweight and obesity in adults. Arch Intern Med. 158:1855–1867. 1998.PubMed/NCBI View Article : Google Scholar

Bray GA, Heisel WE, Afshin A, Jensen MD, Dietz WH, Long M, Kushner RF, Daniels SR, Wadden TA, Tsai AG, et al: The science of obesity management: An endocrine society scientific statement. Endocr Rev. 9:79–132. 2018.PubMed/NCBI View Article : Google Scholar

Jin J: JAMA patient page. Specific medications for weight loss. JAMA. 314(742)2015.PubMed/NCBI View Article : Google Scholar

Hill JO and Wyatt HR: Relapse in obesity treatment: Biology or behavior? Am J Clin Nutr. 69:1064–1065. 1999.PubMed/NCBI View Article : Google Scholar

Wang H and Zhai F: Programme and policy options for preventing obesity in China. Obes Rev. 14 (Suppl 2):S134–S140. 2013.PubMed/NCBI View Article : Google Scholar

Ahrens VM, Bellmann-Sickert K and Beck-Sickinger AG: Peptides and peptide conjugates: Therapeutics on the upward path. Future Med Chem. 4:1567–1586. 2012.PubMed/NCBI View Article : Google Scholar

Fosgerau K and Hoffmann T: Peptide therapeutics: Current status and future directions. Drug Discov Today. 20:122–128. 2015.PubMed/NCBI View Article : Google Scholar

Greenwood HC, Bloom SR and Murphy KG: Peptides and their potential role in the treatment of diabetes and obesity. Rev Diabet Stud. 8:355–368. 2011.PubMed/NCBI View Article : Google Scholar

Wan Y, Xue R, Wang Y, Zhang Q, Huang S, Wu W, Ye H, Zhang Z and Li Y: The effect of neuropeptide Y on brown-like adipocyte's differentiation and activation. Peptides. 63:126–133. 2015.PubMed/NCBI View Article : Google Scholar

Zhang H, Zhang SY, Jiang C, Li Y, Xu G, Xu MJ and Wang X: Intermedin/adrenomedullin 2 polypeptide promotes adipose tissue browning and reduces high-fat diet-induced obesity and insulin resistance in mice. Int J Obes (Lond). 40:852–860. 2016.PubMed/NCBI View Article : Google Scholar

Bordicchia M, Liu D, Amri EZ, Ailhaud G, Dessì-Fulgheri P, Zhang C, Takahashi N, Sarzani R and Collins S: Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. J Clin Invest. 122:1022–1036. 2012.PubMed/NCBI View Article : Google Scholar

Lowell BB and Flier JS: Brown adipose tissue, beta 3-adrenergic receptors, and obesity. Annu Rev Med. 48:307–316. 1997.PubMed/NCBI View Article : Google Scholar

Arner P and Kulyté A: MicroRNA regulatory networks in human adipose tissue and obesity. Nat Rev Endocrinol. 11:276–288. 2015.PubMed/NCBI View Article : Google Scholar

Nedergaard J, Bengtsson T and Cannon B: Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab. 293:E444–E452. 2007.PubMed/NCBI View Article : Google Scholar

Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, Kuo FC, Palmer EL, Tseng YH, Doria A, et al: Identification and importance of brown adipose tissue in adult humans. N Engl J Med. 360:1509–1517. 2009.PubMed/NCBI View Article : Google Scholar

Saito M, Okamatsuogura Y, Matsushita M, Watanabe K, Yoneshiro T, Nio-Kobayashi J, Iwanaga T, Miyagawa M, Kameya T, Nakada K, et al: High incidence of metabolically active brown adipose tissue in healthy adult humans effects of cold exposure and adiposity. Diabetes. 58:1526–1531. 2009.PubMed/NCBI View Article : Google Scholar

Virtanen KA, Lidell ME, Orava J, Heglind M, Westergren R, Niemi T, Taittonen M, Laine J, Savisto NJ, Enerbäck S and Nuutila P: Functional brown adipose tissue in healthy adults. N Engl J Med. 360:1518–1525. 2009.PubMed/NCBI View Article : Google Scholar

Orava J, Nuutila P, Lidell ME, Oikonen V, Noponen T, Viljanen T, Scheinin M, Taittonen M, Niemi T, Enerbäck S and Virtanen KA: Different metabolic responses of human brown adipose tissue to activation by cold and insulin. Cell Metab. 14:272–279. 2011.PubMed/NCBI View Article : Google Scholar

Cannon B and Nedergaard J: Brown adipose tissue: Function and physiological significance. Physiol Rev. 84:277–359. 2004.PubMed/NCBI View Article : Google Scholar

Heath V: Metabolism imaging studies suggest a role for brown adipose tissue in adult humans. Nat Rev Endocrinol. 5(411)2009.

Young P, Arch JR and Ashwell M: Brown adipose tissue in the parametrial fat pad of the mouse. FEBS Lett. 167:10–14. 1984.PubMed/NCBI View Article : Google Scholar

Cousin B, Cinti S, Morroni M, Raimbault S, Ricquier D, Pénicaud L and Casteilla L: Occurrence of brown adipocytes in rat white adipose tissue: Molecular and morphological characterization. J Cell Sci. 103:931–942. 1992.PubMed/NCBI

Wu J, Boström P, Sparks LM, Ye L, Choi JH, Giang AH, Khandekar M, Virtanen KA, Nuutila P, Schaart G, et al: Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell. 150:366–376. 2012.PubMed/NCBI View Article : Google Scholar

Chen Y, Pan R and Pfeifer A: Regulation of brown and beige fat by microRNAs. Pharmacol Ther. 170:1–7. 2017.PubMed/NCBI View Article : Google Scholar

Xue B, Rim JS, Hogan JC, Coulter AA, Koza RA and Kozak LP: Genetic variability affects the development of brown adipocytes in white fat but not in interscapular brown fat. J Lipid Res. 48:41–51. 2007.PubMed/NCBI View Article : Google Scholar

Hoffmann LS, Larson CJ and Pfeifer A: cGMP and brown adipose tissue. Handb Exp Pharmacol. 233:283–299. 2016.PubMed/NCBI View Article : Google Scholar

Lenz LS, Marx J, Chamulitrat W, Kaiser I, Gröne HJ, Liebisch G, Schmitz G, Elsing C, Straub BK, Füllekrug J, et al: Adipocyte-specific inactivation of Acyl-CoA synthetase fatty acid transport protein 4 (Fatp4) in mice causes adipose hypertrophy and alterations in metabolism of complex lipids under high fat diet. J Biol Chem. 286:35578–35587. 2011.PubMed/NCBI View Article : Google Scholar

Fukui Y, Masui S, Osada S, Umesono K and Motojima K: A new thiazolidinedione, NC-2100, which is a weak PPAR-gamma activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice. Diabetes. 49:759–767. 2000.PubMed/NCBI View Article : Google Scholar

Wilson-Fritch L, Nicoloro S, Chouinard M, Lazar MA, Chui PC, Leszyk J, Straubhaar J, Czech MP and Corvera S: Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J Clin Invest. 114:1281–1289. 2004.PubMed/NCBI View Article : Google Scholar

Petrovic N, Walden TB, Shabalina IG, Timmons JA, Cannon B and Nedergaard J: Chronic peroxisome proliferator-activated receptor gamma (PPARgamma) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP1-containing adipocytes molecularly distinct from classic brown adipocytes. J Biol Chem. 285:7153–7164. 2010.PubMed/NCBI View Article : Google Scholar

Hondares E, Mora O, Yubero P, Rodriguez de la Concepción M, Iglesias R, Giralt M and Villarroya F: Thiazolidinediones and rexinoids induce peroxisome proliferator-activated receptor-coactivator (PGC)-1alpha gene transcription: An autoregulatory loop controls PGC-1alpha expression in adipocytes via peroxisome proliferator-activated receptor-gamma coactivation. Endocrinology. 147:2829–2838. 2006.PubMed/NCBI View Article : Google Scholar

Zasloff M: Antimicrobial peptides of multicellular organisms. Nature. 415:389–395. 2002.PubMed/NCBI View Article : Google Scholar

Lauressergues D, Couzigou JM, Clemente HS, Martinez Y, Dunand C, Bécard G and Combier JP: Primary transcripts of microRNAs encode regulatory peptides. Nature. 520:90–93. 2015.PubMed/NCBI View Article : Google Scholar

Szafron LM, Balcerak A, Grzybowska EA, Pienkowska-Grela B, Felisiak-Golabek A, Podgorska A, Kulesza M, Nowak N, Pomorski P, Wysocki J, et al: The novel gene CRNDE encodes a nuclear peptide (CRNDEP) which is overexpressed in highly proliferating tissues. PLoS One. 10(e0127475)2015.PubMed/NCBI View Article : Google Scholar

Matsumoto A, Pasut A, Matsumoto M, Yamashita R, Fung J, Monteleone E, Saghatelian A, Nakayama KI, Clohessy JG and Pandolfi PP: mTORC1 and muscle regeneration are regulated by the LINC00961-encoded SPAR polypeptide. Nature. 541:228–232. 2017.PubMed/NCBI View Article : Google Scholar

Jaffe LA and Egbert JR: Regulation of mammalian oocyte meiosis by intercellular communication within the ovarian follicle. Annu Rev Physiol. 79:237–260. 2017.PubMed/NCBI View Article : Google Scholar

Nguyen AD, Herzog H, Sainsbury A, Neuropeptide Y and peptide YY: Important regulators of energy metabolism. Curr Opin Endocrinol Diabetes Obes. 18:56–60. 2011.PubMed/NCBI View Article : Google Scholar

Saido TC: Metabolism of amyloid β peptide and pathogenesis of Alzheimer's disease. Proc Jpn Acad Ser B Phys Biol Sci. 89:321–339. 2013.PubMed/NCBI View Article : Google Scholar

Celik O, Aydin S, Celik N and Yilmaz M: Peptides: Basic determinants of reproductive functions. Peptides. 72:34–43. 2015.PubMed/NCBI View Article : Google Scholar

Cunha C, Panseri S and Gelain F: Engineering of a 3D nanostructured scaffold made of functionalized self-assembling peptides and encapsulated neural stem cells. Methods Mol Biol. 1058:171–182. 2013.PubMed/NCBI View Article : Google Scholar

Long M, Zhou J, Li D, Zheng L, Xu Z and Zhou S: Long-term over-expression of neuropeptide Y in hypothalamic paraventricular nucleus contributes to adipose tissue insulin resistance partly via the Y5 receptor. PLoS One. 10(e0126714)2015.PubMed/NCBI View Article : Google Scholar

Flier JS and Maratos-Flier E: Leptin's physiologic role: Does the emperor of energy balance have no clothes? Cell Metab. 26:24–26. 2017.PubMed/NCBI View Article : Google Scholar

Rabbani G, Baig MH, Ahmad K and Choi I: Protein-protein interactions and their role in various diseases and their prediction techniques. Curr Protein Pept Sci. 19:948–957. 2018.PubMed/NCBI View Article : Google Scholar

Henry S, Bercu NB, Bobo C, Cullin C, Molinari M and Lecomte S: Interaction of Aβ1-42 peptide or their variant with model membrane of different composition probed by infrared nanospectroscopy. Nanoscale. 10:936–940. 2018.PubMed/NCBI View Article : Google Scholar

Brink HS, van der Lely AJ, Delhanty PJD, Huisman M and van der Linden J: Gestational diabetes mellitus and the ghrelin system. Diabetes Metab. 45:393–395. 2019.PubMed/NCBI View Article : Google Scholar

Hoggard N, Haggarty P, Thomas L and Lea RG: Leptin expression in placental and fetal tissues: Does leptin have a functional role? Biochem Soc Trans. 29:57–63. 2001.PubMed/NCBI View Article : Google Scholar

Picó C, Oliver P, Sánchez J and Palou A: Gastric leptin: A putative role in the short-term regulation of food intake. Br J Nutr. 90:735–741. 2003.PubMed/NCBI View Article : Google Scholar

Telli G BC, Yersal N, Korkusuz P and Gumusel B: Effect of intermedin/adrenomedullin₂ on the pulmonary vascular bed in hypoxia-induced pulmonary hypertensive rats. Life Sci. 192:62–67. 2018.PubMed/NCBI View Article : Google Scholar

Gao S, Ghoshal S, Zhang L, Stevens JR, McCommis KS, Finck BN, Lopaschuk GD and Butler AA: The peptide hormone adropin regulates signal transduction pathways controlling hepatic glucose metabolism in a mouse model of diet-induced obesity. J Biol Chem. 294:13366–13377. 2019.PubMed/NCBI View Article : Google Scholar

Klok MD, Jakobsdottir S and Drent ML: The role of leptin and ghrelin in the regulation of food intake and body weight in humans: A review. Obes Rev. 8:21–34. 2007.PubMed/NCBI View Article : Google Scholar

Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, et al: Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 387:903–908. 1997.PubMed/NCBI View Article : Google Scholar

Jeon JY, Steadward RD, Wheeler GD, Bell G, McCargar L and Harber V: Intact sympathetic nervous system is required for leptin effects on resting metabolic rate in people with spinal cord injury. J Clin Endocrinol Metab. 88:402–407. 2003.PubMed/NCBI View Article : Google Scholar

Farooqi IS, Keogh JM, Kamath S, Jones S, Gibson WT, Trussell R, Jebb SA, Lip GY and O'Rahilly S: Partial leptin deficiency and human adiposity. Nature. 414:34–35. 2001.PubMed/NCBI View Article : Google Scholar

Sobhani I, Vissuzaine C, Buyse M, Kermorgant S, Laigneau JP, Henin D, Bado A and Lewin MJ: Leptin secretion and leptin receptor in human stomach. Gastroenterology. 118(PA34)2000.PubMed/NCBI View Article : Google Scholar

Attele AS, Shi ZQ and Yuan CS: Leptin, gut, and food intake. Biochem Pharmacol. 63:1579–1583. 2002.PubMed/NCBI View Article : Google Scholar

Sobhani I, Buyse M, Goïot H, Weber N, Laigneau JP, Henin D, Soul JC and Bado A: Vagal stimulation rapidly increases leptin secretion in human stomach. Gastroenterology. 122:259–263. 2002.PubMed/NCBI View Article : Google Scholar

Dodd GT, Decherf S, Loh K, Simonds SE, Wiede F, Balland E, Merry TL, Münzberg H, Zhang ZY, Kahn BB, et al: Leptin and insulin act on POMC neurons to promote the browning of white fat. Cell. 160:88–104. 2015.PubMed/NCBI View Article : Google Scholar

Friedman J: The long road to leptin. J Clin Invest. 126:4727–4734. 2016.PubMed/NCBI View Article : Google Scholar

Cui H, López M and Rahmouni K: The cellular and molecular bases of leptin and ghrelin resistance in obesity. Nat Rev Endocrinol. 13:338–351. 2017.PubMed/NCBI View Article : Google Scholar

Procaccini C, La Rocca C, Carbone F, De Rosa V, Galgani M and Matarese G: Leptin as immune mediator: Interaction between neuroendocrine and immune system. Dev Comp Immunol. 66:120–129. 2017.PubMed/NCBI View Article : Google Scholar

Klein S, Horowitz JF, Landt M, Goodrick SJ, Mohamed-Ali V and Coppack SW: Leptin production during early starvation in lean and obese women. Am J Physiol Endocrinol Metab. 278:E280–E284. 2000.PubMed/NCBI View Article : Google Scholar

Chan JL, Kathleen H, Depaoli AM, Veldhuis JD and Mantzoros CS: The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Invest. 111:1409–1421. 2003.PubMed/NCBI View Article : Google Scholar

Duarte-Neves J, de Almeida LP and Cavadas C: Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases. Neurobiol Dis. 95:210–224. 2016.PubMed/NCBI View Article : Google Scholar

Lee SJ, Verma S, Simonds SE, Kirigiti MA, Kievit P, Lindsley SR, Loche A, Smith MS, Cowley MA and Grove KL: Leptin stimulates neuropeptide Y and cocaine amphetamine-regulated transcript coexpressing neuronal activity in the dorsomedial hypothalamus in diet-induced obese mice. J Neurosci. 33:15306–15317. 2013.PubMed/NCBI View Article : Google Scholar

Loh K, Herzog H and Shi YC: Regulation of energy homeostasis by the NPY system. Trends Endocrinol Metab. 26:125–135. 2015.PubMed/NCBI View Article : Google Scholar

Shi YC, Lau J, Lin Z, Zhang H, Zhai L, Sperk G, Heilbronn R, Mietzsch M, Weger S, Huang XF, et al: Arcuate NPY controls sympathetic output and BAT function via a relay of tyrosine hydroxylase neurons in the PVN. Cell Metab. 17:236–248. 2013.PubMed/NCBI View Article : Google Scholar

Kuo LE, Kitlinska JB, Tilan JU, Li L, Baker SB, Johnson MD, Lee EW, Burnett MS, Fricke ST, Kvetnansky R, et al: Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med. 13:803–811. 2007.PubMed/NCBI View Article : Google Scholar

Pandey SC: Anxiety and alcohol abuse disorders: A common role for CREB and its target, the neuropeptide Y gene. Trends Pharmacol Sci. 24:456–460. 2003.PubMed/NCBI View Article : Google Scholar

Meier JJ: GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus. Nat Rev Endocrinol. 8:728–742. 2012.PubMed/NCBI View Article : Google Scholar

Vogel H, Wolf S, Rabasa C, Rodriguez-Pacheco F, Babaei CS, Stöber F, Goldschmidt J, DiMarchi RD, Finan B, Tschöp MH, et al: GLP-1 and estrogen conjugate acts in the supramammillary nucleus to reduce food-reward and body weight. Neuropharmacology. 110:396–406. 2016.PubMed/NCBI View Article : Google Scholar

Baggio LL, Huang Q, Brown TJ and Drucker DJ: Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure. Gastroenterology. 127:546–558. 2004.PubMed/NCBI View Article : Google Scholar

Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, et al: A role for glucagon-like peptide-1 in the central regulation of feeding. Nature. 379:69–72. 1996.PubMed/NCBI View Article : Google Scholar

Perez-Tilve D, Nogueiras R, Mallo F, Benoit SC and Tschoep M: Gut hormones ghrelin, PYY, and GLP-1 in the regulation of energy balance [corrected] and metabolism. Endocrine. 29:61–71. 2006.PubMed/NCBI View Article : Google Scholar

El Bekay R, Coín-Aragüez L, Fernández-García D, Oliva-Olivera W, Bernal-López R, Clemente-Postigo M, Delgado-Lista J, Diaz-Ruiz A, Guzman-Ruiz R, Vázquez-Martínez R, et al: Effects of glucagon-like peptide-1 on the differentiation and metabolism of human adipocytes. Br J Pharmacol. 173:1820–1834. 2016.PubMed/NCBI View Article : Google Scholar

Xu F, Lin B, Zheng X, Chen Z, Cao H, Xu H, Liang H and Weng J: GLP-1 receptor agonist promotes brown remodelling in mouse white adipose tissue through SIRT1. Diabetologia. 59:1059–1069. 2016.PubMed/NCBI View Article : Google Scholar

Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H and Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 402:656–660. 1999.PubMed/NCBI View Article : Google Scholar

Garin MC, Burns CM, Kaul S and Cappola AR: Clinical review: The human experience with ghrelin administration. J Clin Endocrinol Metab. 98:1826–1837. 2013.PubMed/NCBI View Article : Google Scholar

Yakabi K, Kawashima J and Kato S: Ghrelin and gastric acid secretion. World J Gastroenterol. 14:6334–6338. 2008.PubMed/NCBI View Article : Google Scholar

Tritos NA and Kokkotou EG: The physiology and potential clinical applications of ghrelin, a novel peptide hormone. Mayo Clin Proc. 81:653–660. 2006.PubMed/NCBI View Article : Google Scholar

Tschöp M, Smiley DL and Heiman ML: Ghrelin induces adiposity in rodents. Nature. 407:908–913. 2000.PubMed/NCBI View Article : Google Scholar

Shaw AM, Irani BG, Moore MC, Haskell-Luevano C and Millard WJ: Ghrelin-induced food intake and growth hormone secretion are altered in melanocortin 3 and 4 receptor knockout mice. Peptides. 26:1720–1727. 2005.PubMed/NCBI View Article : Google Scholar

Kirchner H, Tong J, Tschöp MH and Pfluger PT: Ghrelin and PYY in the regulation of energy balance and metabolism: Lessons from mouse mutants. Am J Physiol Endocrinol Metab. 298:E909–E919. 2010.PubMed/NCBI View Article : Google Scholar

Mihalache L, Gherasim A, Niţă O, Ungureanu MC, Pădureanu SS, Gavril RS and Arhire LI: Effects of ghrelin in energy balance and body weight homeostasis. Hormones (Athens). 15:186–196. 2016.PubMed/NCBI View Article : Google Scholar

Kitahara A, Takahashi K, Moriya R, Onuma H, Handa K, Sumitani Y, Tanaka T, Katsuta H, Nishida S, Sakurai T, et al: Ghrelin augments the expressions and secretions of proinflammatory adipokines, VEGF120 and MCP-1, in differentiated 3T3-L1 adipocytes. J Cell Physiol. 230:199–209. 2015.PubMed/NCBI View Article : Google Scholar

Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE and Weigle DS: A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 50:1714–1719. 2001.PubMed/NCBI View Article : Google Scholar

van der Lely AJ, Tschöp M, Heiman ML and Ghigo E: Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev. 25:426–457. 2004.PubMed/NCBI View Article : Google Scholar

Bell D and McDermott BJ: Intermedin (adrenomedullin-2): A novel counter-regulatory peptide in the cardiovascular and renal systems. Br J Pharmacol. 153 (Suppl 1):S247–S262. 2008.PubMed/NCBI View Article : Google Scholar

Zhang SY, Lv Y, Zhang H, Gao S, Wang T, Feng J, Wang Y, Liu G, Xu MJ, Wang X and Jiang C: Adrenomedullin 2 improves early obesity-induced adipose insulin resistance by inhibiting the class II MHC in adipocytes. Diabetes. 65:2342–2355. 2016.PubMed/NCBI View Article : Google Scholar

Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Boström EA, Choi JH, Long JZ, et al: A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 481:463–468. 2012.PubMed/NCBI View Article : Google Scholar

Metwally M, Bayoumi A, Romero-Gomez M, Thabet K, John M, Adams LA, Huo X, Aller R, García-Monzón C, Teresa Arias-Loste M, et al: A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3'UTR. J Hepatol. 70:494–500. 2019.PubMed/NCBI View Article : Google Scholar

Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F, Ricart W and Fernández-Real JM: Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab. 98:E769–E778. 2013.PubMed/NCBI View Article : Google Scholar

Pérez-Sotelo D, Roca-Rivada A, Baamonde I, Baltar J, Castro AI, Domínguez E, Collado M, Casanueva FF and Pardo M: Lack of adipocyte-Fndc5/Irisin expression and secretion reduces thermogenesis and enhances adipogenesis. Sci Rep. 7(16289)2017.PubMed/NCBI View Article : Google Scholar

Lee P, Linderman JD, Smith S, Brychta RJ, Wang J, Idelson C, Perron RM, Werner CD, Phan GQ, Kammula US, et al: Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metab. 19:302–309. 2014.PubMed/NCBI View Article : Google Scholar

Ghoshal S, Stevens JR, Billon C, Girardet C, Sitaula S, Leon AS, Rao DC, Skinner JS, Rankinen T, Bouchard C, et al: Adropin: An endocrine link between the biological clock and cholesterol homeostasis. Mol Metab. 8:51–64. 2018.PubMed/NCBI View Article : Google Scholar

Ganesh Kumar K, Zhang J, Gao S, Rossi J, McGuinness OP, Halem HH, Culler MD, Mynatt RL and Butler AA: Adropin deficiency is associated with increased adiposity and insulin resistance. Obesity (Silver Spring). 20:1394–1402. 2012.PubMed/NCBI View Article : Google Scholar

Chen S, Zeng K, Liu QC, Guo Z, Zhang S, Chen XR, Lin JH, Wen JP, Zhao CF, Lin XH and Gao F: Adropin deficiency worsens HFD-induced metabolic defects. Cell Death Dis. 8(e3008)2017.PubMed/NCBI View Article : Google Scholar

Jasaszwili M, Wojciechowicz T, Billert M, Strowski MZ, Nowak KW and Skrzypski M: Effects of adropin on proliferation and differentiation of 3T3-L1 cells and rat primary preadipocytes. Mol Cell Endocrinol. 496(110532)2019.PubMed/NCBI View Article : Google Scholar

Aydin S: Three new players in energy regulation: Preptin, adropin and irisin. Peptides. 56:94–110. 2014.PubMed/NCBI View Article : Google Scholar

Mierzwicka A and Bolanowski M: New peptides players in metabolic disorders. Postepy Hig Med Dosw (Online). 70:881–886. 2016.PubMed/NCBI View Article : Google Scholar

El-Eshmawy M and Abdel Aal I: Relationships between preptin and osteocalcin in obese, overweight, and normal weight adults. Appl Physiol Nutr Metab. 40:218–222. 2015.PubMed/NCBI View Article : Google Scholar

Chen X, Zaro JL and Shen WC: Fusion protein linkers: Property, design and functionality. Adv Drug Deliv Rev. 65:1357–1369. 2013.PubMed/NCBI View Article : Google Scholar

Plamboeck A, Holst JJ, Carr RD and Deacon CF: Neutral endopeptidase 24.11 and dipeptidyl peptidase IV are both involved in regulating the metabolic stability of glucagon-like peptide-1 in vivo. Adv Exp Med Biol. 524:303–312. 2003.PubMed/NCBI View Article : Google Scholar

Tomas E, Wood JA, Stanojevic V and Habener JF: GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice. Regul Pept. 169:43–48. 2011.PubMed/NCBI View Article : Google Scholar

Tomas E, Wood JA, Stanojevic V and Habener JF: Glucagon-like peptide-1(9-36)amide metabolite inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice. Diabetes Obes Metab. 13:26–33. 2011.PubMed/NCBI View Article : Google Scholar

Tomas E, Stanojevic V, McManus K, Khatri A, Everill P, Bachovchin WW and Habener JF: GLP-1(32-36)amide pentapeptide increases basal energy expenditure and inhibits weight gain in obese mice. Diabetes. 64:2409–2419. 2015.PubMed/NCBI View Article : Google Scholar

Jankovic J: Parkinson disease: Exenatide-a drug for diabetes and Parkinson disease? Nat Rev Neurol. 13:643–644. 2017.PubMed/NCBI View Article : Google Scholar

Bondeson DP and Crews CM: Targeted protein degradation by small molecules. Annu Rev Pharmacol Toxicol. 57:107–123. 2017.PubMed/NCBI View Article : Google Scholar

Demirel HC, Dogan T and Tuncbag N: A structural perspective on the modulation of protein-protein interactions with small molecules. Curr Top Med Chem. 18:700–713. 2018.PubMed/NCBI View Article : Google Scholar

Svensson KJ, Long JZ, Jedrychowski MP, Cohen P, Lo JC, Serag S, Kir S, Shinoda K, Tartaglia JA, Rao RR, et al: A secreted Slit2 fragment regulates adipose tissue thermogenesis and metabolic function. Cell Metab. 23:454–466. 2016.PubMed/NCBI View Article : Google Scholar

Phuong TTT, Walker AE, Henson GD, Machin DR, Li DY, Donato AJ and Lesniewski LA: Deletion of Robo4 prevents high-fat diet-induced adipose artery and systemic metabolic dysfunction. Microcirculation. 26(e12540)2019.PubMed/NCBI View Article : Google Scholar

Romere C, Duerrschmid C, Bournat J, Constable P, Jain M, Xia F, Saha PK, Del Solar M, Zhu B, York B, et al: Asprosin, a fasting-induced glucogenic protein hormone. Cell. 165:566–579. 2016.PubMed/NCBI View Article : Google Scholar

Ricci-Cabello I, Herrera MO and Artacho R: Possible role of milk-derived bioactive peptides in the treatment and prevention of metabolic syndrome. Nutr Rev. 70:241–255. 2012.PubMed/NCBI View Article : Google Scholar

Capriotti AL, Cavaliere C, Piovesana S, Samperi R and Laganà A: Recent trends in the analysis of bioactive peptides in milk and dairy products. Anal Bioanal Chem. 408:2677–2685. 2016.PubMed/NCBI View Article : Google Scholar

Sawada Y, Sakamoto Y, Toh M, Ohara N, Hatanaka Y, Naka A, Kishimoto Y, Kondo K and Iida K: Milk-derived peptide Val-Pro-Pro (VPP) inhibits obesity-induced adipose inflammation via an angiotensin-converting enzyme (ACE) dependent cascade. Mol Nutr Food Res. 59:2502–2510. 2016.PubMed/NCBI View Article : Google Scholar

Xu SP, Mao XY, Cheng X and Chen B: Ameliorating effects of casein glycomacropeptide on obesity induced by high-fat diet in male sprague-dawley rats. Food Chem Toxicol. 56:1–7. 2013.PubMed/NCBI View Article : Google Scholar

Cui X, Li Y, Yang L, You L, Wang X, Shi C, Ji C and Guo X: Peptidome analysis of human milk from women delivering macrosomic fetuses reveals multiple means of protection for infants. Oncotarget. 7:63514–63525. 2016.PubMed/NCBI View Article : Google Scholar

Azkargorta M, Escobes I, Iloro I and Elortza F: Mass spectrometric identification of endogenous peptides. Methods Mol Biol. 1719:59–70. 2018.PubMed/NCBI View Article : Google Scholar

Goldberg AL: Protein degradation and protection against misfolded or damaged proteins. Nature. 426:895–899. 2003.PubMed/NCBI View Article : Google Scholar

Lázaro S, Gamarra D and Val M: Proteolytic enzymes involved in MHC class I antigen processing: A guerrilla army that partners with the proteasome. Mol Immunol. 68:72–76. 2015.PubMed/NCBI View Article : Google Scholar

Fricker LD: Analysis of mouse brain peptides using mass spectrometry-based peptidomics: Implications for novel functions ranging from non-classical neuropeptides to microproteins. Mol Biosyst. 6:1355–1365. 2010.PubMed/NCBI View Article : Google Scholar

Castro LM, Berti DA, Russo LC, Coelho V, Gozzo FC, Oliveira V and Ferro ES: Similar intracellular peptide profile of TAP1/β2 microglobulin double-knockout mice and C57BL/6 wild-type mice as revealed by peptidomic analysis. AAPS J. 12:608–616. 2010.PubMed/NCBI View Article : Google Scholar

Gelman JS, Juan S, Castro LM, Ferro ES and Fricker LD: Peptidomic analysis of human cell lines. J Proteome Res. 10:1583–1592. 2011.PubMed/NCBI View Article : Google Scholar

Cunha FM, Berti DA, Ferreira ZS, Klitzke CF, Markus RP and Ferro ES: Intracellular peptides as natural regulators of cell signaling. J Biol Chem. 283:24448–24459. 2008.PubMed/NCBI View Article : Google Scholar

Haynes CM, Yang Y, Blais SP, Neubert TA and Ron D: The matrix peptide exporter HAF-1 signals a mitochondrial UPR by activating the transcription factor ZC376.7 in C. elegans. Mol Cell. 37:529–540. 2010.PubMed/NCBI View Article : Google Scholar

Berti DA, Russo LC, Castro LM, Cruz L, Gozzo FC, Heimann JC, Lima FB, Oliveira AC, Andreotti S, Prada PO, et al: Identification of intracellular peptides in rat adipose tissue: Insights into insulin resistance. Proteomics. 12:2668–2681. 2012.PubMed/NCBI View Article : Google Scholar

Liu Y, Luo B, Shi R, Wang J, Liu Z, Liu W, Wang S and Zhang Z: Nonerythropoietic erythropoietin-derived peptide suppresses adipogenesis, inflammation, obesity and insulin resistance. Sci Rep. 5(15134)2015.PubMed/NCBI View Article : Google Scholar

Sodhi K, Maxwell K, Yan Y, Liu J, Chaudhry MA, Getty M, Xie Z, Abraham NG and Shapiro JI: pNaKtide inhibits Na/K-ATPase reactive oxygen species amplification and attenuates adipogenesis. Sci Adv. 1(e1500781)2015.PubMed/NCBI View Article : Google Scholar

Ogden CL, Carroll MD, Kit BK and Flegal KM: Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA. 311:806–814. 2014.PubMed/NCBI View Article : Google Scholar

Ferro ES, Rioli V, Castro LM and Fricker LD: Intracellular peptides: From discovery to function. EuPA Open Proteom. 3:143–151. 2014.

Forner F, Kumar C, Luber CA, Fromme T, Klingenspor M and Mann M: Proteome differences between brown and white fat mitochondria reveal specialized metabolic functions. Cell Metab. 10:324–335. 2009.PubMed/NCBI View Article : Google Scholar

Iepsen EW, Torekov SS and Holst JJ: Therapies for inter-relating diabetes and obesity-GLP-1 and obesity. Expert Opin Pharmacother. 15:2487–2500. 2014.PubMed/NCBI View Article : Google Scholar

Desilets AR, Dhakal-Karki S and Dunican KC: Role of metformin for weight management in patients without type 2 diabetes. Ann Pharmacother. 42:817–826. 2008.PubMed/NCBI View Article : Google Scholar

Gao Y, Wang X, Huang F, Cui X, Li Y, Wang X, Cao Y, Xu P, Xie K, Tang R, et al: Identification and characterization of metformin on peptidomic profiling in human visceral adipocytes. J Cell Biochem. 119:1866–1878. 2018.PubMed/NCBI View Article : Google Scholar

Lee C, Zeng J, Drew BG, Sallam T, Martin-Montalvo A, Wan J, Kim SJ, Mehta H, Hevener AL, de Cabo R and Cohen P: The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 21:443–454. 2015.PubMed/NCBI View Article : Google Scholar

Bessesen DH and Van Gaal LF: Progress and challenges in anti-obesity pharmacotherapy. Lancet Diabetes Endocrinol. 6:237–248. 2018.PubMed/NCBI View Article : Google Scholar

Iwasaki Y, Sendo M, Dezaki K, Hira T, Sato T, Nakata M, Goswami C, Aoki R, Arai T, Kumari P, et al: GLP-1 release and vagal afferent activation mediate the beneficial metabolic and chronotherapeutic effects of D-allulose. Nat Commun. 9(113)2018.PubMed/NCBI View Article : Google Scholar

Jones B, Bloom SR, Buenaventura T, Tomas A and Rutter GA: Control of insulin secretion by GLP-1. Peptides. 100:75–84. 2018.PubMed/NCBI View Article : Google Scholar

Carter A, Hendrikse J, Lee N, Yücel M, Verdejo-Garcia A, Andrews ZB and Hall W: The neurobiology of ‘food addiction’ and its implications for obesity treatment and policy. Annu Rev Nutr. 36:105–128. 2016.PubMed/NCBI View Article : Google Scholar

Rebello CJ and Greenway FL: Obesity medications in development. Expert Opin Investig Drugs. 29:63–71. 2020.PubMed/NCBI View Article : Google Scholar